Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthAlgeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.

View Premium plansBrowse free archive reports